Our top pick for
XP Inc is a capital markets business based in the US. XP shares (XP) are listed on the NASDAQ and all prices are listed in US Dollars.
|52-week range||USD$15.5 - USD$52.53|
|50-day moving average||USD$45.6194|
|200-day moving average||USD$42.977|
|Wall St. target price||USD$47.7|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$0.3716|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing XP stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of XP's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
XP's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 64x. In other words, XP shares trade at around 64x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
|Gross profit TTM||USD$5.5 billion|
|Return on assets TTM||2.3%|
|Return on equity TTM||23.06%|
|Market capitalisation||USD$23.9 billion|
TTM: trailing 12 months
There are currently 3.2 million XP shares held short by investors – that's known as XP's "short interest". This figure is 9.9% down from 3.5 million last month.
There are a few different ways that this level of interest in shorting XP shares can be evaluated.
XP's "short interest ratio" (SIR) is the quantity of XP shares currently shorted divided by the average quantity of XP shares traded daily (recently around 1.3 million). XP's SIR currently stands at 2.42. In other words for every 100,000 XP shares traded daily on the market, roughly 2420 shares are currently held short.
However XP's short interest can also be evaluated against the total number of XP shares, or, against the total number of tradable XP shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case XP's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 XP shares in existence, roughly 10 shares are currently held short) or 0.0266% of the tradable shares (for every 100,000 tradable XP shares, roughly 27 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against XP.
Find out more about how you can short XP stock.
We're not expecting XP to pay a dividend over the next 12 months.
XP Inc. operates technology-driven financial services platform that provides financial products and services in Brazil. It provides broker-dealer services for high-net worth customers and institutional clients; product structuring and capital markets services for corporate clients and issuers of fixed income products; advisory services for mass-affluent and institutional clients; and wealth management services for high-net-worth clients. The company also offers XP Educação, an online financial education portal that offers seminars, classes, and learning tools to help teach individuals a range of topics, such as basics of investing, techniques, and investment strategies, as well as insurance brokerage services. In addition, it operates XP Platform, an open product platform that provides clients to access investment products in the market, including equity and fixed income securities, mutual and hedge funds, structured products, life insurance, pension plans, real-estate investment funds, and others. The company was founded in 2001 and is based in São Paulo, Brazil.
Everything we know about the Achilles Therapeutics plc IPO, plus information on how to buy in.
Everything we know about the SEMrush Holdings Inc IPO, plus information on how to buy in.
Everything we know about the ChargePoint IPO, plus information on how to buy in.
Everything we know about the Kaltura Inc IPO, plus information on how to buy in.
Everything we know about the Rocket Lab IPO, plus information on how to buy in.
Everything we know about the Soho House IPO, plus information on how to buy in.
Everything we know about the VIZIO IPO, plus information on how to buy in.
Everything we know about the IDW Media Holdings Inc IPO, plus information on how to buy in.
Everything we know about the Karooooo Ltd IPO, plus information on how to buy in.
Everything we know about the Connect Biopharma Holdings Limited IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.